News
-
-
PRESS RELEASE
Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock
Journal of Critical Care publishes positive results from biomarker-guided analysis of AdrenoMed’s Phase II trial in septic shock, showing efficacy of enibarcimab. Precision medicine approach for sepsis treatment -
-
PRESS RELEASE
AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock
AdrenoMed AG receives FDA Fast Track designation for enibarcimab, a potential first treatment for septic shock addressing underlying pathophysiology. Precision medicine approach shows reduced mortality in clinical trials -
-